Yüklüyor......
Current approaches and future directions in the treatment of HER2-positive breast cancer
Human epidermal growth factor receptor 2 (HER2), a member of the ErbB family of transmembrane receptor tyrosine kinases, is amplified in 20–30% of invasive breast cancers. HER2 amplification is associated with metastasis and reduced survival. Two HER2-directed therapies have been approved by the Uni...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3835685/ https://ncbi.nlm.nih.gov/pubmed/22658319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2012.04.008 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|